New drug aims to reverse Cancer-Related wasting

NCT ID NCT07168226

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times

Summary

This study tests a new drug called ASCA101 for cachexia, a condition where people with cancer lose weight and muscle. About 135 adults with certain solid tumors will receive ASCA101, an active control, or a placebo for 12 weeks. The main goal is to see if the drug helps increase body weight and is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CACHEXIA; CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ajou University Hospital

    Gyeonggi-do, Suwon-si, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Chung-Ang University Gwangmyeong Hospital

    Gyeonggi-do, Gwangmyeong-si, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Korea University Anam Hospital

    Seoul, Seongbuk-gu, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • National Cancer Center

    Gyeonggi-do, Goyang-si, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Samsung Medical Center

    Seoul, Gangnam-gu, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Seoul ST. Mary's hospital

    Seoul, Seocho-gu, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.